Kearns Evan Insider Profile
11 Followers
Kearns Evan, CLO at Cogent Biosciences, holds 109.40K shares in Cogent Biosciences (Ticker: COGT), holds ― shares in Agenus (Ticker: AGEN). Most recently, Kearns Evan Sold ― shares of Cogent Biosciences on Dec 30, 2025 for an estimated value of $2.52M.
Kearns Evan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Kearns Evan
Kearns Evan's Trading History
Cogent Biosciences
Dec 30, 2025
CLO
Informative Sell
2.52M
$3.65M
Agenus
―
VP & GC
―
―
List of latest transactions for each holding click on a transaction to see Kearns Evan's performance on stock
You May Also Like
Kearns Evan insider profile FAQ
What is the percentage of profitable transactions made by Kearns Evan?
The percentage of profitable transactions made by Kearns Evan is ―.
What is the average return per transaction made by Kearns Evan?
The average return per transaction made by Kearns Evan is ―.
What stocks does Kearns Evan hold?
Kearns Evan holds: COGT, AGEN stocks.
What was Kearns Evan’s latest transaction?
Kearns Evan latest transaction was an Informative Sell of $2.52M.
What was Kearns Evan's most profitable transaction?
Kearns Evan’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kearns Evan's role in Cogent Biosciences?
Kearns Evan's role in Cogent Biosciences is CLO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.